Cite
HARVARD Citation
Terra, S. et al. (2017). Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone. Diabetes, obesity & metabolism. 19 (5), pp. 721-728. [Online].